| Examiner | Number of Cases | 3YGR |
|---|---|---|
| Examiner Bram | 0 | 0% |
| Examiner Carr | 432 | 87% |
| Examiner Claytor (SPE) | 40 | 5% |
| Examiner Crews | 8 | 25% |
| Examiner Fowler | 0 | 0% |
| Examiner Johnson | 7 | 0% |
| Examiner Lee | 431 | 49% |
| Examiner Lewis | 434 | 75% |
| Examiner Rahmani | 614 | 86% |
| Examiner Rao | 549 | 73% |
| Examiner Sawyer | 332 | 76% |
| Examiner Shiao | 751 | 81% |
| Examiner Shiao | 467 | 72% |
| Examiner Vishnyakova | 8 | 0% |
| Art Unit 1691 | 4073 | 75% |
| Number | Class Description |
|---|---|
| 514 | Drug, bio-affecting and body treating compositions |
| 536 | Organic compounds -- part of the class 532-570 series |
| 564 | Organic compounds -- part of the class 532-570 series |
| 562 | Organic compounds -- part of the class 532-570 series |
| 554 | Organic compounds -- part of the class 532-570 series |
| 560 | Organic compounds -- part of the class 532-570 series |
| 568 | Organic compounds -- part of the class 532-570 series |
| 546 | Organic compounds -- part of the class 532-570 series |
| 424 | Drug, bio-affecting and body treating compositions |
| 544 | Organic compounds -- part of the class 532-570 series |
Art Unit 1691's grant rate is lower than that of Group 1690 and lower than that of the USPTO.
Below is the grant rate timeline for Art Unit 1691, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.